Long non‑coding RNAs, lipid metabolism and cancer (Review)
- Authors:
- Zhen-Dong Zhang
- Xin-Rui Hou
- Xiao-Lan Cao
- Xiao-Ping Wang
-
Affiliations: Graduate School, Xizang Minzu University, Xianyang, Shaanxi 712082, P.R. China, Key Laboratory of High‑Altitude Hypoxia Environment and Life Health, Joint Laboratory for Research on Active Components and Pharmacological Mechanism of Tibetan Medicine, Materia Medica of Tibetan Medical Research Center of Tibet, School of Medicine, Xizang Minzu University, Xianyang, Shaanxi 712082, P.R. China - Published online on: August 17, 2023 https://doi.org/10.3892/etm.2023.12169
- Article Number: 470
-
Copyright: © Zhang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
This article is mentioned in:
Abstract
 |
|
Xia C, Dong X, Li H, Cao M, Sun D, He S, Yang F, Yan X, Zhang S, Li N and Chen W: Cancer statistics in China and United States, 2022: Profiles, trends, and determinants. Chin Med J (Engl). 135:584–590. 2022.PubMed/NCBI View Article : Google Scholar | |
|
National Bureau of Statistics of China. [Cited 2023 June 30]. China Statistical Yearbook, 2023. Available from: http://www.stats.gov.cn/tjsj/ndsj/. | |
|
McCabe EM and Rasmussen TP: lncRNA involvement in cancer stem cell function and epithelial-mesenchymal transitions. Semin Cancer Biol. 75:38–48. 2021.PubMed/NCBI View Article : Google Scholar | |
|
Cheng C, Geng F, Cheng X and Guo D: Lipid metabolism reprogramming and its potential targets in cancer. Cancer Commun (Lond). 38(27)2018.PubMed/NCBI View Article : Google Scholar | |
|
Bian X, Liu R, Meng Y, Xing D, Xu D and Lu Z: Lipid metabolism and cancer. J Exp Med. 218(e20201606)2021.PubMed/NCBI View Article : Google Scholar | |
|
Liu C, Li H, Chu F, Zhou X, Xie R, Wei Q, Yang S, Li T, Liang S and Lü M: Long non-coding RNAs: Key regulators involved in metabolic reprogramming in cancer (review). Oncol Rep. 45(54)2021.PubMed/NCBI View Article : Google Scholar | |
|
Ghafouri-Fard S and Taheri M: Long non-coding RNA signature in gastric cancer. Exp Mol Pathol. 113(104365)2020.PubMed/NCBI View Article : Google Scholar | |
|
Taniue K and Akimitsu N: The functions and unique features of LncRNAs in cancer development and tumorigenesis. Int J Mol Sci. 22(632)2021.PubMed/NCBI View Article : Google Scholar | |
|
Statello L, Guo CJ, Chen LL and Huarte M: Gene regulation by long non-coding RNAs and its biological functions. Nat Rev Mol Cell Bio. 22:96–118. 2021.PubMed/NCBI View Article : Google Scholar | |
|
Park EG, Pyo SJ, Cui Y, Yoon SH and Nam JW: Tumor immune microenvironment lncRNAs. Brief Bioinform. 23(bbab504)2022.PubMed/NCBI View Article : Google Scholar | |
|
Shi L, Duan R, Sun Z, Jia Q, Wu W, Wang F, Liu J, Zhang H and Xue X: LncRNA GLTC targets LDHA for succinylation and enzymatic activity to promote progression and radioiodine resistance in papillary thyroid cancer. Cell Death Differ. 30:1517–1532. 2023.PubMed/NCBI View Article : Google Scholar | |
|
Mas AM and Huarte M: Long Noncoding RNA signatures as cancer biomarkers. J Clin Oncol. 41:3059–3062. 2023.PubMed/NCBI View Article : Google Scholar | |
|
Huang Z, Zhang M, Li J and Lou C: Long non-coding RNA MAFG-AS1: A promising therapeutic target for human cancers. Biomed Pharmacother. 163(114756)2023.PubMed/NCBI View Article : Google Scholar | |
|
Yang K, Zhang W, Zhong L, Xiao Y, Sahoo S, Fassan M, Zeng K, Magee P, Garofalo M and Shi L: Long non-coding RNA HIF1A-As2 and MYC form a double-positive feedback loop to promote cell proliferation and metastasis in KRAS-driven non-small cell lung cancer. Cell Death Differ. 30:1533–1549. 2023.PubMed/NCBI View Article : Google Scholar | |
|
Abdi E, Latifi-Navid S, Abdi F and Taherian-Esfahani Z: Emerging circulating MiRNAs and LncRNAs in upper gastrointestinal cancers. Expert Rev Mol Diagn. 20:1121–1138. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Qi FF, Yang Y, Zhang H and Chen H: Long non-coding RNAs: Key regulators in oxaliplatin resistance of colorectal cancer. Biomed Pharmacother. 128(110329)2020.PubMed/NCBI View Article : Google Scholar | |
|
Chen M, Zhang C, Liu W, Du X, Liu X and Xing B: Long noncoding RNA LINC01234 promotes hepatocellular carcinoma progression through orchestrating aspartate metabolic reprogramming. Mol Ther. 30:2354–2369. 2022.PubMed/NCBI View Article : Google Scholar | |
|
Zhang Y, Liu Q and Liao Q: Long noncoding RNA: A dazzling dancer in tumor immune microenvironment. J Exp Clin Canc Res. 39(231)2020.PubMed/NCBI View Article : Google Scholar | |
|
Xue W, Zheng Y, Shen Z, Li L, Fan Z, Wang W, Zhu Z, Zhai Y, Zhao J and Kan Q: Involvement of long non-coding RNAs in the progression of esophageal cancer. Cancer Commun (Lond). 41:371–388. 2021.PubMed/NCBI View Article : Google Scholar | |
|
Zhang H, Wang J, Wang Y, Li J, Zhao L, Zhang T and Liao X: Long non-coding LEF1-AS1 sponge miR-5100 regulates apoptosis and autophagy in gastric cancer cells via the miR-5100/DEK/AMPK-mTOR axis. Int J Mol Sci. 23(4787)2022.PubMed/NCBI View Article : Google Scholar | |
|
Verma S, Sahu BD and Mugale MN: Role of lncRNAs in hepatocellular carcinoma. Life Sci. 325(121751)2023.PubMed/NCBI View Article : Google Scholar | |
|
Toker J, Iorgulescu JB, Ling AL, Villa GR, Gadet JAMA, Parida L, Getz G, Wu CJ, Reardon DA, Chiocca EA and Mineo M: Clinical importance of the lncRNA NEAT1 in cancer patients treated with immune checkpoint inhibitors. Clin Cancer Res. 29:2226–2238. 2023.PubMed/NCBI View Article : Google Scholar | |
|
Guan Z, Wang Y, Wang Y, Liu X, Wang Y, Zhang W, Chi X, Dong Y, Liu X, Shao S and Zhan Q: Long non-coding RNA LOC100133669 promotes cell proliferation in oesophageal squamous cell carcinoma. Cell Prolif. 53(e12750)2020.PubMed/NCBI View Article : Google Scholar | |
|
Xing C, Sun SG, Yue ZQ and Bai F: Role of lncRNA LUCAT1 in cancer. Biomed Pharmacother. 134(111158)2021.PubMed/NCBI View Article : Google Scholar | |
|
Chi J, Liu T, Shi C, Luo H, Wu Z, Xiong B, Liu S and Zeng Y: Long non-coding RNA LUCAT1 promotes proliferation and invasion in gastric cancer by regulating miR-134-5p/YWHAZ axis. Biomed Pharmacother. 118(109201)2019.PubMed/NCBI View Article : Google Scholar | |
|
Zhou Q, Hou Z, Zuo S, Zhou X, Feng Y, Sun Y and Yuan X: LUCAT1 promotes colorectal cancer tumorigenesis by targeting the ribosomal protein L40-MDM2-p53 pathway through binding with UBA52. Cancer Sci. 110:1194–1207. 2019.PubMed/NCBI View Article : Google Scholar | |
|
Gu X, Chu Q, Zheng Q, Wang J and Zhu H: The dual functions of the long noncoding RNA CASC15 in malignancy. Biomed Pharmacother. 135(111212)2021.PubMed/NCBI View Article : Google Scholar | |
|
Wu Q, Xiang S, Ma J, Hui P, Wang T, Meng W, Shi M and Wang Y: Long non-coding RNA CASC15 regulates gastric cancer cell proliferation, migration and epithelial mesenchymal transition by targeting CDKN1A and ZEB1. Mol Oncol. 12:799–813. 2018.PubMed/NCBI View Article : Google Scholar | |
|
Yao XM, Tang JH, Zhu H and Jing Y: High expression of LncRNA CASC15 is a risk factor for gastric cancer prognosis and promote the proliferation of gastric cancer. Eur Rev Med Pharmaco. 21:5661–5667. 2017.PubMed/NCBI View Article : Google Scholar | |
|
Ghafouri-Fard S, Esmaeili M and Taheri M: H19 lncRNA: Roles in tumorigenesis. Biomed Pharmacother. 123(109774)2020.PubMed/NCBI View Article : Google Scholar | |
|
Hashemi M, Moosavi MS, Abed HM, Dehghani M, Aalipour M, Heydari EA, Behroozaghdam M, Entezari M, Salimimoghadam S, Gunduz ES, et al: Long non-coding RNA (lncRNA) H19 in human cancer: From proliferation and metastasis to therapy. Pharmacol Res. 184(106418)2022.PubMed/NCBI View Article : Google Scholar | |
|
Ding D, Li C, Zhao T, Li D, Yang L and Zhang B: LncRNA H19/miR-29b-3p/PGRN axis promoted epithelial-mesenchymal transition of colorectal cancer cells by acting on Wnt signaling. Mol Cells. 41:423–435. 2018.PubMed/NCBI View Article : Google Scholar | |
|
Zheng Q, Zhang Q, Yu X, He Y and Guo W: FENDRR: A pivotal, cancer-related, long non-coding RNA. Biomed Pharmacother. 137(111390)2021.PubMed/NCBI View Article : Google Scholar | |
|
Luo T, Zhao J, Lu Z, Bi J, Pang T, Cui H, Yang B, Li W, Wang Y, Wu S and Xue X: Characterization of long non-coding RNAs and MEF2C-AS1 identified as a novel biomarker in diffuse gastric cancer. Transl Oncol. 11:1080–1089. 2018.PubMed/NCBI View Article : Google Scholar | |
|
Ghafouri-Fard S, Shoorei H, Dashti S, Branicki W and Taheri M: Expression profile of lncRNAs and miRNAs in esophageal cancer: Implications in diagnosis, prognosis, and therapeutic response. J Cell Physiol. 235:9269–9290. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Yang Y, Jin L, He J, Wang R, Wang Y, Bai J, Chen Y and Luo Z: Upregulation LncRNA MEG3 expression suppresses proliferation and metastasis in melanoma via miR-208/SOX4. Mol Cell Biochem. 478:407–414. 2023.PubMed/NCBI View Article : Google Scholar | |
|
Soghala S, Harsiny K, Momeni P, Hatami M, Kholghi Oskooei V, Hussen BM, Taheri M and Ghafouri-Fard S: Down-regulation of LINC-ROR, HOXA-AS2 and MEG3 in gastric cancer. Heliyon. 8(e11155)2022.PubMed/NCBI View Article : Google Scholar | |
|
Butler LM, Perone Y, Dehairs J, Lupien LE, de Laat V, Talebi A, Loda M, Kinlaw WB and Swinnen JV: Lipids and cancer: Emerging roles in pathogenesis, diagnosis and therapeutic intervention. Adv Drug Deliver Rev. 159:245–293. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Liu X, Hu J and Liu B: Characteristics and clinical significance of lipid metabolism in patients with gastrointestinal stromal tumor. Lipids Health Dis. 21(1)2022.PubMed/NCBI View Article : Google Scholar | |
|
Machala M, Procházková J, Hofmanová J, Králiková L, Slavík J, Tylichová Z, Ovesná P, Kozubík A and Vondráček J: Colon cancer and perturbations of the sphingolipid metabolism. Int J Mol Sci. 20(6051)2019.PubMed/NCBI View Article : Google Scholar | |
|
Pakiet A, Kobiela J, Stepnowski P, Sledzinski T and Mika A: Changes in lipids composition and metabolism in colorectal cancer: A review. Lipids Health Dis. 18(29)2019.PubMed/NCBI View Article : Google Scholar | |
|
Zheng M, Wang W, Liu J, Zhang X and Zhang R: Lipid metabolism in cancer cells. Adv Exp Med Biol. 1316:49–69. 2021.PubMed/NCBI View Article : Google Scholar | |
|
Broadfield LA, Pane AA, Talebi A, Swinnen JV and Fendt SM: Lipid metabolism in cancer: New perspectives and emerging mechanisms. Dev Cell. 56:1363–1393. 2021.PubMed/NCBI View Article : Google Scholar | |
|
Bacci M, Lorito N, Smiriglia A and Morandi A: Fat and furious: Lipid metabolism in antitumoral therapy response and resistance. Trends Cancer. 7:198–213. 2021.PubMed/NCBI View Article : Google Scholar | |
|
Zheng L, Jiang J, Liu Y, Zheng X and Wu C: Correlations of recurrence after radical surgery for esophageal cancer with glucose-lipid metabolism, insulin resistance, inflammation, stress and serum p53 expression. J BUON. 24:1666–1672. 2019.PubMed/NCBI | |
|
Luo Q, Zheng N, Jiang L, Wang T, Zhang P, Liu Y, Zheng P, Wang W, Xie G, Chen L, et al: Lipid accumulation in macrophages confers protumorigenic polarization and immunity in gastric cancer. Cancer Sci. 111:4000–4011. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Mejia JC and Pasko J: Primary liver cancers: intrahepatic cholangiocarcinoma and hepatocellular carcinoma. Surg Clin North Am. 100:535–549. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Tiong TY, Weng PW, Wang CH, Setiawan SA, Yadav VK, Pikatan NW, Fong IH, Yeh CT, Hsu CH and Kuo KT: Targeting the SREBP-1/Hsa-Mir-497/SCAP/FASN oncometabolic axis inhibits the cancer stem-like and chemoresistant phenotype of non-small cell lung carcinoma cells. Int J Mol Sci. 23(7283)2022.PubMed/NCBI View Article : Google Scholar | |
|
Sun Q, Yu X, Peng C, Liu N, Chen W, Xu H, Wei H, Fang K, Dong Z, Fu C, et al: Activation of SREBP-1c alters lipogenesis and promotes tumor growth and metastasis in gastric cancer. Biomed Pharmacother. 128(110274)2020.PubMed/NCBI View Article : Google Scholar | |
|
Pascual G, Domínguez D, Elosúa-Bayes M, Beckedorff F, Laudanna C, Bigas C, Douillet D, Greco C, Symeonidi A, Hernández I, et al: Dietary palmitic acid promotes a prometastatic memory via Schwann cells. Nature. 599:485–490. 2021.PubMed/NCBI View Article : Google Scholar | |
|
Zhang X, Li X, Xiong G, Yun F, Feng Y, Ni Q, Wu N, Yang L, Yi Z, Zhang Q, et al: Palmitic acid promotes lung metastasis of melanomas via the TLR4/TRIF-Peli1-pNF-κB pathway. Metabolites. 12(1132)2022.PubMed/NCBI View Article : Google Scholar | |
|
Yin H, Li W, Mo L, Deng S, Lin W, Ma C, Luo Z, Luo C and Hong H: Adipose triglyceride lipase promotes the proliferation of colorectal cancer cells via enhancing the lipolytic pathway. J Cell Mol Med. 25:3963–3975. 2021.PubMed/NCBI View Article : Google Scholar | |
|
Wen YA, Xiong X, Zaytseva YY, Napier DL, Vallee E, Li AT, Wang C, Weiss HL, Evers BM and Gao T: Downregulation of SREBP inhibits tumor growth and initiation by altering cellular metabolism in colon cancer. Cell Death Dis. 9(265)2018.PubMed/NCBI View Article : Google Scholar | |
|
Hall Z, Chiarugi D, Charidemou E, Leslie J, Scott E, Pellegrinet L, Allison M, Mocciaro G, Anstee QM, Evan GI, et al: Lipid remodeling in hepatocyte proliferation and hepatocellular carcinoma. Hepatology. 73:1028–1044. 2021.PubMed/NCBI View Article : Google Scholar | |
|
Wang Z, Qin H, Liu S, Sheng J and Zhang X: Precision diagnosis of hepatocellular carcinoma. Chin Med J (Engl). 136:1155–1165. 2023.PubMed/NCBI View Article : Google Scholar | |
|
Pope ER III, Kimbrough EO, Vemireddy LP, Surapaneni PK, Copland JR III and Mody K: Aberrant lipid metabolism as a therapeutic target in liver cancer. Expert Opin Ther Tar. 23:473–483. 2019.PubMed/NCBI View Article : Google Scholar | |
|
Li D and Li Y: The interaction between ferroptosis and lipid metabolism in cancer. Signal Transduct Target Ther. 5(108)2020.PubMed/NCBI View Article : Google Scholar | |
|
Chen J, Ding C, Chen Y, Hu W, Yu C, Peng C, Feng X, Cheng Q, Wu W, Lu Y, et al: ACSL4 reprograms fatty acid metabolism in hepatocellular carcinoma via c-Myc/SREBP1 pathway. Cancer Lett. 502:154–165. 2021.PubMed/NCBI View Article : Google Scholar | |
|
Buechler C and Aslanidis C: Role of lipids in pathophysiology, diagnosis and therapy of hepatocellular carcinoma. Biochim Biophys Acta Mol Cell Biol Lipids. 1865(158658)2020.PubMed/NCBI View Article : Google Scholar | |
|
Lin W, Zhou Q, Wang CQ, Zhu L, Bi C, Zhang S, Wang X and Jin H: LncRNAs regulate metabolism in cancer. Int J Biol Sci. 16:1194–1206. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Xu Y, Qiu M, Shen M, Dong S, Ye G, Shi X and Sun M: The emerging regulatory roles of long non-coding RNAs implicated in cancer metabolism. Mol Ther. 29:2209–2218. 2021.PubMed/NCBI View Article : Google Scholar | |
|
Li D, Cheng M, Niu Y, Chi X, Liu X, Fan J, Fan H, Chang Y and Yang W: Identification of a novel human long non-coding RNA that regulates hepatic lipid metabolism by inhibiting SREBP-1c. Int J Biol Sci. 13:349–357. 2017.PubMed/NCBI View Article : Google Scholar | |
|
Li D, Guo L, Deng B, Li M, Yang T, Yang F and Yang Z: Long non-coding RNA HR1 participates in the expression of SREBP-1c through phosphorylation of the PDK1/AKT/FoxO1 pathway. Mol Med Rep. 18:2850–2856. 2018.PubMed/NCBI View Article : Google Scholar | |
|
Gong CY, Tang R, Nan W, Zhou KS and Zhang HH: Role of SNHG16 in human cancer. Clin Chim Acta. 503:175–180. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Yu Y, Dong JT, He B, Zou YF, Li XS, Xi CH and Yu Y: LncRNA SNHG16 induces the SREBP2 to promote lipogenesis and enhance the progression of pancreatic cancer. Future Oncol. 15:3831–3844. 2019.PubMed/NCBI View Article : Google Scholar | |
|
Panzitt K, Tschernatsch MM, Guelly C, Moustafa T, Stradner M, Strohmaier HM, Buck CR, Denk H, Schroeder R, Trauner M and Zatloukal K: Characterization of HULC, a novel gene with striking up-regulation in hepatocellular carcinoma, as noncoding RNA. Gastroenterology. 132:330–342. 2007.PubMed/NCBI View Article : Google Scholar | |
|
Du Y, Kong G, You X, Zhang S, Zhang T, Gao Y, Ye L and Zhang X: Elevation of highly up-regulated in liver cancer (HULC) by hepatitis B virus X protein promotes hepatoma cell proliferation via down-regulating p18. J Biol Chem. 287:26302–26311. 2012.PubMed/NCBI View Article : Google Scholar | |
|
Cui M, Xiao Z, Wang Y, Zheng M, Song T, Cai X, Sun B, Ye L and Zhang X: Long noncoding RNA HULC modulates abnormal lipid metabolism in hepatoma cells through an miR-9-mediated RXRA signaling pathway. Cancer Res. 75:846–857. 2015.PubMed/NCBI View Article : Google Scholar | |
|
Hu B, Lin JZ, Yang XB and Sang XT: Aberrant lipid metabolism in hepatocellular carcinoma cells as well as immune microenvironment: A review. Cell Prolif. 53(e12772)2020.PubMed/NCBI View Article : Google Scholar | |
|
Christensen LL, True K, Hamilton MP, Nielsen MM, Damas ND, Damgaard CK, Ongen H, Dermitzakis E, Bramsen JB, Pedersen JS, et al: SNHG16 is regulated by the Wnt pathway in colorectal cancer and affects genes involved in lipid metabolism. Mol Oncol. 10:1266–1282. 2016.PubMed/NCBI View Article : Google Scholar | |
|
Guo S, Zhang Y, Wang S, Yang T, Ma B, Li X, Zhang Y and Jiang X: LncRNA PCA3 promotes antimony-induced lipid metabolic disorder in prostate cancer by targeting MIR-132-3 P/SREBP1 signaling. Toxicol Lett. 348:50–58. 2021.PubMed/NCBI View Article : Google Scholar | |
|
Ma J, Feng J and Zhou X: Long non-coding RNA HAGLROS regulates lipid metabolism reprogramming in intrahepatic cholangiocarcinoma via the mTOR signaling pathway. Exp Mol Pathol. 115(104466)2020.PubMed/NCBI View Article : Google Scholar | |
|
Wang X, Liu H, Zhang Q, Zhang X, Qin Y, Zhu G, Dang J, Wang F, Yang X and Fan R: LINC00514 promotes lipogenesis and tumor progression in esophageal squamous cell carcinoma by sponging miR-378a-5p to enhance SPHK1 expression. Int J Oncol. 59(86)2021.PubMed/NCBI View Article : Google Scholar | |
|
Xu K, Xia P, Gongye X, Zhang X, Ma S, Chen Z, Zhang H, Liu J, Liu Y, Guo Y, et al: A novel lncRNA RP11-386G11.10 reprograms lipid metabolism to promote hepatocellular carcinoma progression. Mol Metab. 63(101540)2022.PubMed/NCBI View Article : Google Scholar | |
|
Duan J, Huang Z, Nice EC, Xie N, Chen M and Huang C: Current advancements and future perspectives of long noncoding RNAs in lipid metabolism and signaling. J Adv Res. 48:105–123. 2023.PubMed/NCBI View Article : Google Scholar | |
|
Chen J, Alduais Y, Zhang K, Zhu X and Chen B: CCAT1/FABP5 promotes tumour progression through mediating fatty acid metabolism and stabilizing PI3K/AKT/mTOR signalling in lung adenocarcinoma. J Cell Mol Med. 25:9199–9213. 2021.PubMed/NCBI View Article : Google Scholar | |
|
Wang H, Zhang Y, Guan X, Li X, Zhao Z, Gao Y, Zhang X and Chen R: An integrated transcriptomics and proteomics analysis implicates lncRNA MALAT1 in the regulation of lipid metabolism. Mol Cell Proteomics. 20(100141)2021.PubMed/NCBI View Article : Google Scholar | |
|
Liu S, Sun Y, Hou Y, Yang L, Wan X, Qin Y, Liu Y, Wang R, Zhu P, Teng Y and Liu M: A novel lncRNA ROPM-mediated lipid metabolism governs breast cancer stem cell properties. J Hematol Oncol. 14(178)2021.PubMed/NCBI View Article : Google Scholar | |
|
Liu Y, Li C, Fang L, Wang L, Liu H, Tian H, Zheng Y, Fan T and He J: Lipid metabolism-related lncRNA SLC25A21-AS1 promotes the progression of oesophageal squamous cell carcinoma by regulating the NPM1/c-Myc axis and SLC25A21 expression. Clin Transl Med. 12(e944)2022.PubMed/NCBI View Article : Google Scholar | |
|
Tito C, Ganci F, Sacconi A, Masciarelli S, Fontemaggi G, Pulito C, Gallo E, Laquintana V, Iaiza A, De Angelis L, et al: LINC00174 is a novel prognostic factor in thymic epithelial tumors involved in cell migration and lipid metabolism. Cell Death Dis. 11(959)2020.PubMed/NCBI View Article : Google Scholar | |
|
Bo H, Zhang W, Zhong X, Chen J, Liu Y, Cheong KL, Fan P and Tang S: LINC00467, driven by copy number amplification and DNA demethylation, is associated with oxidative lipid metabolism and immune infiltration in breast cancer. Oxid Med Cell Longev. 2021(4586319)2021.PubMed/NCBI View Article : Google Scholar | |
|
Zuo X, Chen Z, Gao W, Zhang Y, Wang J, Wang J, Cao M, Cai J, Wu J and Wang X: M6A-mediated upregulation of LINC00958 increases lipogenesis and acts as a nanotherapeutic target in hepatocellular carcinoma. J Hematol Oncol. 13(5)2020.PubMed/NCBI View Article : Google Scholar | |
|
He W, Liang B, Wang C, Li S, Zhao Y, Huang Q, Liu Z, Yao Z, Wu Q, Liao W, et al: MSC-regulated lncRNA MACC1-AS1 promotes stemness and chemoresistance through fatty acid oxidation in gastric cancer. Oncogene. 38:4637–4654. 2019.PubMed/NCBI View Article : Google Scholar | |
|
Lin Y, Xiao Y, Liu S, Hong L, Shao L and Wu J: Role of a lipid metabolism-related lncRNA signature in risk stratification and immune microenvironment for colon cancer. Bmc Med Genomics. 15(221)2022.PubMed/NCBI View Article : Google Scholar | |
|
Liu X, Liang Y, Song R, Yang G, Han J, Lan Y, Pan S, Zhu M, Liu Y, Wang Y, et al: Long non-coding RNA NEAT1-modulated abnormal lipolysis via ATGL drives hepatocellular carcinoma proliferation. Mol Cancer. 17(90)2018.PubMed/NCBI View Article : Google Scholar | |
|
Lu C, Ma J and Cai D: Increased HAGLR expression promotes non-small cell lung cancer proliferation and invasion via enhanced de novo lipogenesis. Tumour Biol. 39(1010428317697574)2017.PubMed/NCBI View Article : Google Scholar | |
|
Mazar J, Zhao W, Khalil AM, Lee B, Shelley J, Govindarajan SS, Yamamoto F, Ratnam M, Aftab MN, Collins S, et al: The functional characterization of long noncoding RNA SPRY4-IT1 in human melanoma cells. Oncotarget. 5:8959–8969. 2014.PubMed/NCBI View Article : Google Scholar |
